Journals / Turkish Journal of Obstetrics and Gynecology / 2019 / Cilt: 16 - Sayı: 4

Cervix human papilloma virus positivity: Does it cause sexual dysfunction?

Serviks human papilloma virüsü pozitifliği: Cinsel işlev bozukluğuna neden olur mu?

Pages
235–241
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Sexual functioning was affected by neither HPV test results (positive/negative) nor time from diagnosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To investigate whether testing positive for human papilloma virus (HPV) in cervical screening has an impact on female sexual functioning.Materials and Methods: This study was designed as a single-center, prospective, descriptive-cross-sectional study and 300 women who received HPV testing inour hospital [HPV-positive (n=187) or HPV-negative (n=113)].
📊
Key Findings & Data:The Arizona Sexual Experiences (ASEX) scale and Female Sexual Functioning index (FSFI) wereadministered to study participants during face-to-face interviews.Results: No significant differences were found between women who were HPV-positive and HPV-negative in sexual functions as assessed using the ASEX and FSFIscales (p=0.343 and p=0.604, respectively).
💡
Conclusion & Impact:Sexual functioning was affected by neither HPV test results (positive/negative) nor time from diagnosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To investigate whether testing positive for human papilloma virus (HPV) in cervical screening has an impact on female sexual functioning.Materials and Methods: This study was designed as a single-center, prospective, descriptive-cross-sectional study and 300 women who received HPV testing inour hospital [HPV-positive (n=187) or HPV-negative (n=113)]. The Arizona Sexual Experiences (ASEX) scale and Female Sexual Functioning index (FSFI) wereadministered to study participants during face-to-face interviews.Results: No significant differences were found between women who were HPV-positive and HPV-negative in sexual functions as assessed using the ASEX and FSFIscales (p=0.343 and p=0.604, respectively). In addition, the analyses addressing whether sexual functioning was affected by a positive test result, at diagnosis orduring the follow-up (before 2 weeks, 2 weeks-1 month, 1-3 months, 3-6 months, 6 months-1 year and over 1 year) revealed no significant differences betweenHPV-positive and HPV-negative women in sexual functioning (p>0.05). Sexual dysfunction was less common in married women than in the ASEX scale (p=0.03),and this difference was not detected when the FSFI scale was applied. The incidence of dysfunction was more frequent in working women than in retirees (p=0.006,p=0.01).Conclusion: Educational attainment, socioeconomic status, age, employment status, and marital status were found to have statistically significant effects on sexualfunctioning. Sexual functioning was affected by neither HPV test results (positive/negative) nor time from diagnosis.

Özet

Amaç: Çalışmadaki amacımız servikal human papilloma virüsler (HPV) taramasında pozitif sonuç alan hastalarda cinsel fonksiyonlarda değişiklik olup olmadığını araştırmaktır. Gereç ve Yöntemler: Tek merkezli prospektif, tanımlayıcı-kesitsel olarak planlanan bu çalışma HPV testi yapılan 300 kadın hasta rastgele seçildi [HPV pozitif (n=187) ve HPV negatif (n=113)]. Yüz yüze görüşülerek Arizona Cinsel Yaşantılar Ölçeği (ACY) ve Kadın Cinsel İşlev Ölçeği (FSFI) uygulandı. Bulgular: HPV pozitif ve negatif hastalar ile cinsel fonksiyonlar arasındaki ilişki açısından bakıldığında ACY ve FSFI ölçeklerinde anlamlı bir farklılık olmadığı izlenmiştir (p=0,343, 0,604). Ayrıca HPV tanısı alması anında ve takip süresince seksüel fonksiyonların etkilenip etkilenmemesine bakıldığında (tanıdan sonraki ilk 2 haftada, 2 hafta-1 ay, 1-3 ay, 3-6 ay, 6-12 ay ve 1 yıldan fazla) anlamlı bir farklılık bulunmamıştır (p>0,05). Evli kadınlarda ACY ölçeğine göre cinsel fonksiyon bozukluğu (CFB) daha az görülmektedir (p=0,03), bu fark FSFI ölçeği uygulandığında saptanmamıştır. Çalışan kadınlarda CFB görülme oranı çalışmayan ve emeklilere göre daha sıktır (p=0,006, 0,01). Sonuç: Eğitim düzeyi, sosyo-ekonomik durum, yaş, işte çalışıyor olmak ve medeni durumun cinsel fonksiyon üzerine istatistiksel olarak anlamlı olarak bulunmuştur. HPV tanısının pozitif ya da negatif olması ve HPV pozitif tanısı alan hastalarda tanı süresinin cinsel fonksiyonlar üzerine etkisi saptanmamıştır.

🔖

Cite This Article

SAKİN, Ö., ANGIN, A. D., AKALIN, E. E., KOYUNCU, K., UZUN, S. B., GİRAY, B. (2022). Cervix human papilloma virus positivity: Does it cause sexual dysfunction?. Turkish Journal of Obstetrics and Gynecology, Cilt: 16 - Sayı: 4, 235–241. https://ajindex.com/articles/612983

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. World Health Organization Sexual Health. (2012) Retrieved on 30 November 2012 from http://www.int/reproductivehealth/topics_ health/sh_definitions/en/ 2. Ibrahim ZM, Ahmed MR, Sayed Ahmed WA. Prevalence and risk factors for female sexual dysfunction among Egyptian women. Arch Gynecol Obstet 2013;287:1173-80. 3. Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int 2004;72:52-7. 4. Oksuz E, Malhan S. Prevalence and risk factors for female sexual dysfunction in Turkish women. J Urol 2006;175:654-8; discussion 658. 5. De Souza A, Dwyer P, Charity M, Thomas E, Ferreira C, Schierlitz L. The effects of mode delivery on postpartum sexual function: a prospective study. BJOG 2015;122:1410-8. 6. Clayton AH, Groth J. Etiology of female sexual dysfunction. Womens Health (Lond) 2013;9:135-7. 7. Jundt K, Peschers U, Kentenich H. The investigation and treatment of female pelvic floor dysfunction. Dtsch Arztebl Int 2015;112:564- 74. 8. Basson R. Human sex-response cycles. J Sex Marital Ther 2001;27:33-43. 9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Washington, DC: American Psychiatric Publishing; 2013. 10. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006;194:1044-57. 11. Scrivener LD, Green J, Hetherton J, Brook G. Disclosure of anogenital warts to sexual partners. Sex Transm Infect 2008;84:179-82. 12. Maggino T, Casadei D, Panontin E, Fadda E, Zampieri M, Dona M, et al. Impact of an HPV diagnosis on the quality of life in young women. Gynecol Oncol 2007;107:S175-9. 13. McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact. BJOG 2004;111:1437-43. 14. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208. 15. Oksuz E, Malhan S. Reliability and validity of the Female Sexual Function Index in Turkish population. Turkiye Klinikleri J Med Sci 2005;25:393-9. 16. Wiegel M1, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff sc